Core Viewpoint - The company, Aier Eye Hospital Group (300015.SZ), has approved the acquisition of partial equity in 39 institutions, including Bozhou Aier and Lianyungang Aier, with a total transaction amount of 963.0228 million yuan, funded by its own capital [1] Group 1: Strategic Goals - The company is focused on enhancing operational levels and deepening its "graded chain" development model to improve service coverage [1] - The company aims to achieve its mission of ensuring eye health rights for all, regardless of wealth, through both organic growth and external mergers and acquisitions [1] Group 2: Market Positioning - The external mergers and acquisitions are crucial for increasing market share and competitiveness in the ophthalmology medical market [1] - The planned acquisition will accelerate the national network construction and improve the layout of service points, solidifying the company's leading position in the eye care market [1]

Core Viewpoint - Aier Eye Hospital Group (300015.SZ) has approved the acquisition of partial equity in 39 institutions, including Bozhou Aier and Lianyungang Aier, with a total transaction amount of 963.0228 million yuan, funded by its own capital [1] Group 1: Strategic Goals - The company is focused on enhancing operational levels and deepening the "graded chain" development model to improve service coverage [1] - The company aims to achieve its mission of ensuring eye health rights for all, regardless of wealth, through both organic growth and external mergers and acquisitions [1] Group 2: Market Positioning - External mergers and acquisitions are crucial for increasing market share and competitiveness, helping to solidify the company's leading position in the ophthalmology market [1] - The acquisition is expected to accelerate the national network construction and improve the layout of service points, thereby strengthening the company's development foundation [1]